Credé Prophylaxis and Neonatal Corneal Infection With Herpesvirus
- 1 May 1974
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 91 (5) , 386-388
- https://doi.org/10.1001/archopht.1974.03900060398013
Abstract
One possible explanation for the rarity of ocular herpesvirus infections in newborn infants may be the universal application of Credé prophylaxis. To test this hypothesis, a clinically used silver nitrate preparation was instilled in the eyes of rabbits 20 minutes after an ocular inoculation with a strain of type 1 or a strain of type 2 herpesvirus (HSV). With the strain of type 1 HSV, silver nitrate prevented infection with smaller inocula (3,000 plaqueforming units [PFU]), but not with a larger dose (30,000 PFU). With the strain of herpes type 2 there was not prevention of disease with either concentration of inoculum (1,000 and 10,000 PFU). The practical importance of silver nitrate prophylaxis on herpetic infection in the newborn may be small.Keywords
This publication has 4 references indexed in Scilit:
- Neonatal herpes simplex infectionsPublished by Elsevier ,2011
- Neonatal Herpes Simplex Infection Limited to the CorneaArchives of Ophthalmology (1950), 1970
- Ocular Involvement in Neonatal Herpes Simplex Virus InfectionArchives of Ophthalmology (1950), 1969
- The Inactivation of Herpes-Simplex Virus by Chemical Agents*American Journal of Ophthalmology, 1961